PRESS-RELEASE ·Filed May 5, 2026

RGEN

Repligen Corporation
BULLISH
Impact 7/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▲ Bullish

The strong beat and raised EPS guidance, combined with margin expansion and strategic divestiture, support a bullish read-through for RGEN. Monitor upcoming quarterly results for continued organic growth trajectory and Transformation Office execution — the reiterated 9%-13% organic revenue guide provides a clear benchmark.

DirectionBullish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
RGEN ▲ +14.32% at T+60d
LONG call ✓ call won +14.32% · α vs SPY +11.58% · entry $125.61 → $143.60
Entry anchored
May 5, 2026
via day open
T+1d
+0.12%
call +0.12% · α -1.27%
$125.76
settled 5mo ago
T+5d
-9.56%
call -9.56% · α -11.55%
$113.60
settled 5mo ago
T+20d
-3.57%
call -3.57% · α -8.52%
$121.13
settled 4mo ago
T+60d
+14.32%
call +14.32% · α +11.58%
$143.60
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Repligen reported Q1 2026 adjusted EPS of $0.48, beating the $0.38 consensus by 26.3%, and revenue of $194M (+15% YoY, +11% organic) above the $192.2M estimate. The company raised its full-year adjusted EPS guidance to $1.97-$2.05 (from prior $1.92-$2.00) while reiterating 9%-13% organic revenue growth, signaling confidence in margin expansion and operational execution.

Key Financial Metrics

EPS
$0.48
est $0.38 · +26.3%
Revenue
$194.0M
est $192.2M · +0.9% · +15.0% YoY
Rating
strong beat
Guidance
$803M-$833M
raised
Free Cash Flow
$23.6M
Gross Margin
55.7%

Key Facts

  • Q1 2026 adjusted EPS $0.48 vs consensus $0.38 (+26.3% beat)
  • Q1 2026 revenue $194M vs consensus $192.2M (+15% reported, +11% organic YoY)
  • GAAP EPS $0.15 vs $0.10 YoY; adjusted EPS $0.48 vs $0.39 YoY (+23%)
  • Adjusted operating margin expanded 160bps to 15.4% (from 13.8% YoY)
  • Full-year 2026 adjusted EPS guidance raised to $1.97-$2.05 (from $1.92-$2.00)
  • Full-year 2026 revenue guidance reiterated at $803M-$833M (9%-13% organic growth)
  • Divested non-core Polymem business (2025 rev $7M, operating loss) to sharpen focus
  • Cash and marketable securities $785M; operating cash flow $28.3M in Q1

Financial Impact

EPS beat of $0.10 vs consensus (+26%) and revenue beat of ~$1.8M (+0.9%)

epsrevenueoperating marginguidance

Risk Factors

  • GAAP EPS of $0.15 remains low due to $13.8M loss on sale of Polymem and $9.8M intangible amortization
  • Organic growth guidance of 9%-13% implies deceleration from Q1's 11% organic pace
  • China partnership and tariff exposure add execution and geopolitical risk

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (29 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3287476
8 reports for RGEN
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +25.89%Jul 22, 2026
Filters
Rows
Reports for RGEN — sortable, filterable
TypeNow
Aug 25, 2026
5w ago
S-4
NEUTRAL ★ 6/10
$181.69 $184.53▲ +1.56%▲ +0.59%$185.41 (+2.05%)
Jul 28, 2026
9w ago
8-K
BULLISH ★ 7/10
$145.34 $181.69▲ +25.01%▲ +21.63%$185.41 (+27.57%)
Jul 22, 2026
10w ago
425 / 8-K
BULLISH ★ 7/10
$140.09 $176.36▲ +25.89%▲ +22.99%$185.41 (+32.35%)
Jul 22, 2026
10w ago
Press Release
BULLISH ★ 7/10
$140.09 $176.36▲ +25.89%▲ +22.99%$185.41 (+32.35%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 5/10
$130.59 $144.24▲ +10.45%▲ +8.67%$185.41 (+41.98%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$125.61 $121.13▼ −3.57%▼ −8.52%$185.41 (+47.61%)
May 5, 2026
21w ago
Press Release
BULLISH ★ 7/10
$125.61 $121.13▼ −3.57%▼ −8.52%$185.41 (+47.61%)
Apr 22, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$124.40 $108.52▼ −12.77%▼ −15.93%$185.41 (+49.04%)
Showing 8 of 8

US Market Status

Market Open — Closes in 4h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 5, 2026